Risk factors for adults with Philadelphia‐chromosome‐positive acute lymphoblastic leukaemia in remission treated with allogeneic bone marrow transplantation: the potential of real‐time quantitative reverse‐transcription polymerase chain reaction [PDF]
Seok Lee+11 more
openalex +1 more source
Nilotinib Versus Imatinib in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (Ph+ CML): A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs). [PDF]
Zafar F+10 more
europepmc +1 more source
Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR‐ABL‐positive acute lymphoblastic leukemia in Taiwan [PDF]
Bor‐Sheng Ko+10 more
openalex +1 more source
High-dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome–positive chronic phase chronic myeloid leukemia [PDF]
Hagop M. Kantarjian+12 more
openalex +1 more source
Chronic Myeloid Leukemia with a Rare Philadelphia Chromosome Variant Involving Chromosome 16. [PDF]
Bahashwan SM.
europepmc +1 more source
Computer aided analysis of additional chromosome aberrations in Philadelphia chromosome positive acute lymphoblastic leukaemia using a simplified computer readable cytogenetic notation [PDF]
Jutta Bradtke+7 more
openalex +1 more source
Patient-reported outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib: results from the PhALLCON trial. [PDF]
Ashaye A+14 more
europepmc +1 more source
Efficacy and safety of olverembatinib as maintenance therapy after allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia. [PDF]
Kong J+14 more
europepmc +1 more source
Analysis of the impact of imatinib mesylate therapy on the prognosis of patients with Philadelphia chromosome–positive chronic myelogenous leukemia treated with interferon‐α regimens for early chronic phase [PDF]
Hagop M. Kantarjian+9 more
openalex +1 more source